Innoviva
INVA
$15.16
Share price
-0.07%
Change (1 day)
28.47%
Change (1 year)
Categories
Innoviva (INVA) - P/B ratio
P/B ratio as of April 2024 : 1.42
According to Innoviva's latest financial reports the company has a price-to-book ratio of 1.42.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Innoviva - P/B ratio (from 2004 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.52 | -6.81% |
| 2022-12-31 | 1.63 | -28.3% |
| 2021-12-31 | 2.28 | 10.28% |
| 2020-12-31 | 2.07 | -50.7% |
| 2019-12-31 | 4.19 | -62.2% |
| 2018-12-31 | 11.1 | -286.18% |
| 2017-12-31 | -5.96 | 81.25% |
| 2016-12-31 | -3.29 | -6.91% |
| 2015-12-31 | -3.53 | -52.08% |
| 2014-12-31 | -7.37 | -155.44% |
| 2013-12-31 | 13.3 | -14.04% |
| 2012-12-31 | 15.5 | -164.43% |
| 2011-12-31 | -24.0 | -73.29% |
| 2010-12-31 | -89.8 | 1922.72% |
| 2009-12-31 | -4.44 | -7.98% |
| 2008-12-31 | -4.83 | -73.15% |
| 2007-12-31 | -18.0 | -161.25% |
| 2006-12-31 | 29.3 | 74.59% |
| 2005-12-31 | 16.8 | 237.79% |
| 2004-12-31 | 4.98 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6171 | -56.55% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.44 | 1.40% | 🇺🇸 USA |